Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies.

Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Tremoli E.

Ann Med. 2015 May 8:1-8. [Epub ahead of print]

PMID:
25953378
2.

Ankylosing spondylitis and posture control: the role of visual input.

De Nunzio AM, Iervolino S, Zincarelli C, Di Gioia L, Rengo G, Multari V, Peluso R, Di Minno MN, Pappone N.

Biomed Res Int. 2015;2015:948674. doi: 10.1155/2015/948674. Epub 2015 Mar 3.

3.

Management of arthropathy in inflammatory bowel diseases.

Peluso R, Manguso F, Vitiello M, Iervolino S, Di Minno MN.

Ther Adv Chronic Dis. 2015 Mar;6(2):65-77. doi: 10.1177/2040622314563929. Review.

4.

Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies.

Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN.

Thromb Haemost. 2015 Apr 29;113(5):916-30. doi: 10.1160/TH14-11-0921. Epub 2015 Feb 26.

PMID:
25716931
5.

Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.

Caso F, Cantarini L, Morisco F, Del Puente A, Ramonda R, Fiocco U, Lubrano E, Peluso R, Caso P, Galeazzi M, Punzi L, Scarpa R, Costa L.

Expert Opin Biol Ther. 2015 May;15(5):641-50. doi: 10.1517/14712598.2015.1011616. Epub 2015 Feb 4.

PMID:
25652590
6.

Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies.

Ambrosino P, Lupoli R, Di Minno A, Iervolino S, Peluso R, Di Minno MN.

Ann Med. 2014 Dec;46(8):693-702. doi: 10.3109/07853890.2014.959559. Epub 2014 Oct 13.

PMID:
25307359
7.

Biological therapies for spondyloarthritis.

Bruner V, Atteno M, Spanò A, Scarpa R, Peluso R.

Ther Adv Musculoskelet Dis. 2014 Jun;6(3):92-101. doi: 10.1177/1759720X14535512. Review.

8.

Extra-articular manifestations in psoriatic arthritis patients.

Peluso R, Iervolino S, Vitiello M, Bruner V, Lupoli G, Di Minno MN.

Clin Rheumatol. 2015 Apr;34(4):745-53. doi: 10.1007/s10067-014-2652-9. Epub 2014 May 8.

PMID:
24803233
9.

Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments.

Di Minno MN, Iervolino S, Peluso R, Di Minno A, Ambrosino P, Scarpa R; CaRRDs Study Group.

J Rheumatol. 2014 Apr;41(4):714-22. doi: 10.3899/jrheum.130850. Epub 2014 Feb 15.

PMID:
24532831
10.

Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies.

Di Minno MN, Ambrosino P, Peluso R, Di Minno A, Lupoli R, Dentali F; CaRRDs Study Group.

Ann Med. 2014 Mar;46(2):73-83. doi: 10.3109/07853890.2013.874661. Epub 2014 Jan 27. Review.

PMID:
24460516
11.

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.

Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R; CaRRDs Study Group.

Ann Rheum Dis. 2014 Jun;73(6):1157-62. doi: 10.1136/annrheumdis-2012-202812. Epub 2013 Jun 14.

12.

Enteropathic spondyloarthritis: from diagnosis to treatment.

Peluso R, Di Minno MN, Iervolino S, Manguso F, Tramontano G, Ambrosino P, Esposito C, Scalera A, Castiglione F, Scarpa R.

Clin Dev Immunol. 2013;2013:631408. doi: 10.1155/2013/631408. Epub 2013 Apr 15. Review.

13.

Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Peluso R, Cafaro G, Di Minno A, Iervolino S, Ambrosino P, Lupoli G, Di Minno MN.

Clin Rheumatol. 2013 Jun;32(6):743-53. doi: 10.1007/s10067-013-2252-0. Epub 2013 Apr 16. Review.

PMID:
23588881
14.

Effectiveness of a rehabilitative programme in improving fatigue and function in rheumatoid arthritis patients treated with biologics: a pilot study.

Di Gioia L, Zincarelli C, Di Minno MN, Rengo G, Peluso R, Spanò A, Iervolino S, Pappone N.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):285-8. Epub 2013 Feb 13.

PMID:
23406843
15.

Discovertebral erosions in patients with enteropathic spondyloarthritis.

Peluso R, DI Minno MN, Bruner V, Soscia E, Castiglione F, Manguso F, Iervolino S, Scarpa R.

J Rheumatol. 2012 Dec;39(12):2332-40. doi: 10.3899/jrheum.120415. Epub 2012 Oct 15.

PMID:
23070989
16.

Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study.

Di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Tarantino G, Scarpa R.

Arthritis Res Ther. 2012 Oct 4;14(5):R211. doi: 10.1186/ar4049.

17.

Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management.

Russolillo A, Iervolino S, Peluso R, Lupoli R, Di Minno A, Pappone N, Di Minno MN.

Rheumatology (Oxford). 2013 Jan;52(1):62-7. doi: 10.1093/rheumatology/kes242. Epub 2012 Sep 18. Review.

18.

Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis.

Sanduzzi A, Bocchino M, Atteno M, Costa L, Ponticiello A, Matarese A, Spanò A, Bruner V, Peluso R, Aquino MM, Del Puente A, Scarpa R.

J Rheumatol Suppl. 2012 Jul;89:82-5. doi: 10.3899/jrheum.120252.

PMID:
22751601
19.

New developments in magnetic resonance imaging of the nail unit.

Soscia E, Sirignano C, Catalano O, Atteno M, Costa L, Caso F, Peluso R, Bruner V, Aquino MM, Del Puente A, Salvatore M, Scarpa R.

J Rheumatol Suppl. 2012 Jul;89:49-53. doi: 10.3899/jrheum.120243.

PMID:
22751592
20.

Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis.

di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, di Minno G.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):141-7. doi: 10.1002/acr.21711.

PMID:
22514189
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk